Castleview Partners’s HCA Healthcare HCA Stock Holding History

Castleview Partners’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-644	Closed	-$223K	–	177
2025 Q1	$223K	Buy	+644	New	+$207K	0.15%	163

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Castleview Partners's HCA Position: Q2 2025 in Review

Castleview Partners sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 644 shares — an estimated $223K sold.

Castleview Partners first reported a position in HCA in Q1 2025 and held it in 1 quarter. The position peaked at $223K in Q1 2025. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

Castleview Partners reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
Castleview Partners sold 644 HCA Healthcare shares in Q2 2025, an estimated $223K.
Castleview Partners first reported a position in HCA Healthcare in Q1 2025 and held it in 1 quarter.
Castleview Partners's HCA Healthcare position peaked at $223K in Q1 2025.
1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Castleview Partners's 13F filing for Q2 2025, filed 16 Jul 2025.